Holen Sie sich die Stockscreener-App
305.25
1.96%
-6.18
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$311.43
Offen:
$307.95
24-Stunden-Volumen:
1.11M
Relative Volume:
0.81
Marktkapitalisierung:
$59.40B
Einnahmen:
$325.78B
Nettoeinkommen (Verlust:
$1.64B
KGV:
36.72
EPS:
8.3139
Netto-Cashflow:
$3.61B
1W Leistung:
-1.95%
1M Leistung:
-1.49%
6M Leistung:
-10.52%
1J Leistung:
+4.32%
1-Tages-Spanne:
$299.34
$308.64
1-Wochen-Bereich:
$299.34
$313.69
52-Wochen-Spanne:
$271.00
$377.54
Cencora Inc Stock (COR) Company Profile
Firmenname
Cencora Inc
Sektor
Branche
Telefon
610-727-7000
Adresse
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
305.38 | 60.69B | 325.78B | 1.64B | 3.61B | 8.3139 |
MCK
Mckesson Corp
|
810.87 | 102.28B | 397.96B | 4.55B | 9.64B | 34.77 |
CAH
Cardinal Health Inc
|
193.19 | 48.38B | 244.67B | 1.68B | 5.51B | 6.9487 |
HSIC
Henry Schein Inc
|
73.64 | 8.73B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.18 | 2.00B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-29 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | Hochstufung | Jefferies | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-09-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2023-01-31 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-10-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-12 | Fortgesetzt | Evercore ISI | In-line |
| 2021-02-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-01-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Eingeleitet | Mizuho | Neutral |
| 2020-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Eingeleitet | Barclays | Underweight |
| 2020-06-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-04-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-11 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Eingeleitet | Guggenheim | Buy |
| 2019-04-10 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-10 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-26 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Eingeleitet | Berenberg | Buy |
| 2018-07-17 | Fortgesetzt | Stifel | Hold |
| 2018-04-09 | Eingeleitet | MoffettNathanson | Buy |
| 2018-03-12 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Eingeleitet | JP Morgan | Neutral |
| 2017-09-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cencora Inc Aktie (COR) Neueste Nachrichten
Cencora Inc. Stock (US15135B1017): Q1 2026 Earnings Preview Ahead of Report - AD HOC NEWS
Vanguard Capital Management reports 14.21M Cencora (COR) shares; 7.3% stake - Stock Titan
Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
What you need to know ahead of Cencora's earnings release - MSN
William Blair initiates coverage of Cencora (COR) with market perform recommendation - MSN
Is It Time To Reassess Cencora (COR) After Its Recent Share Price Pullback? - simplywall.st
William Blair initiates Cencora stock coverage with Market Perform By Investing.com - Investing.com South Africa
William Blair initiates Cencora stock coverage with Market Perform - Investing.com
COR to expand Retina Consultants of America with $1.1B EyeSouth deal - MSN
CareMetx, LLC acquired Patient Services and Free Goods Pharmacy Operations of Cencora from Cencora, Inc.. - marketscreener.com
Cencora’s animal health unit to merge with Covetrus in $3.5B transaction - MSN
Assessing Cencora (COR) Valuation After Recent Share Pullback And Premium P/E Multiple - simplywall.st
The MidCap Growth Fund's Cencora Inc(COR) Holding History - GuruFocus
Axecap Investments LLC Purchases 3,428 Shares of Cencora, Inc. $COR - MarketBeat
Cencora Expands Specialty Business with $1.1 Billion EyeSouth Acquisition - HarianBasis.co
Is Cencora Building A Stronger Specialty Healthcare Network? - Kalkine Media
Munich Reinsurance Co Stock Corp in Munich Has $8.70 Million Holdings in Cencora, Inc. $COR - MarketBeat
Teacher Retirement System of Texas Has $22.02 Million Stake in Cencora, Inc. $COR - MarketBeat
Cencora Expands Into Retina Care With EyeSouth Deal And EPS Focus - simplywall.st
Cencora Inc. stock underperforms Friday when compared to competitors - MarketWatch
Cencora, Inc. (COR) Expands Into Retina Services Business in $1.1B Deal - Insider Monkey
Cencora, Inc. $COR Shares Bought by B. Metzler seel. Sohn & Co. AG - MarketBeat
Cencora, Inc. (COR) Stock Price Today - MEXC Exchange
Here's Why You Should Hold Cencora Stock in Your Portfolio Now - MSN
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
KLP Kapitalforvaltning AS Decreases Holdings in Cencora, Inc. $COR - MarketBeat
M&T Bank Corp Increases Stock Position in Cencora, Inc. $COR - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Sells 5,241 Shares of Cencora, Inc. $COR - MarketBeat
Cencora (COR) Q4 Outlook | Cencora Inc. posts in-line EPS on solid revenue growthCommunity Risk Signals - Cổng thông tin điện tử tỉnh Lào Cai
Cencora, Inc. Stock Hits Day Low Amid Price Pressure at $311.96 - Markets Mojo
A Look at Cencora Inc (COR) After 3.3% Decline -- GF Value $288. - GuruFocus
Cencora Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Lobbying Update: $1,150,000 of CENCORA INC. lobbying was just disclosed - Quiver Quantitative
Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch
Cencora (COR) Stock Working Order (Smart Money Exits) 2026-04-20Chart Patterns - Cổng thông tin điện tử tỉnh Tây Ninh
Cencora, Inc. $COR Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
TD Waterhouse Canada Inc. Raises Holdings in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. (COR) Stock Analysis: Evaluating a 23% Potential Upside in the Healthcare Distribution Sector - DirectorsTalk Interviews
Farther Finance Advisors LLC Grows Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora Inc. stock (US15135B1017): Why does its pharmaceutical distribution dominance matter more no - AD HOC NEWS
Assessing Whether Cencora (COR) Is Undervalued Given Mixed Returns And A Rich Earnings Multiple - simplywall.st
Cencora, Inc. (COR) signs binding agreement to expand retina network with EyeSouth acquisition - MSN
Institute for Wealth Management LLC. Has $2.78 Million Stock Position in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Cencora Inc stock (US03073E1055): Why Google Discover changes matter more now - AD HOC NEWS
Mizuho Maintains Cencora (COR) Outperform Recommendation - MSN
Cencora Inc stock (US03073E1055): Why its pharmaceutical distribution leadership matters more now fo - AD HOC NEWS
Moran Wealth Management LLC Sells 5,004 Shares of Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Bought by Asset Management One Co. Ltd. - MarketBeat
KBC Group NV Sells 151,164 Shares of Cencora, Inc. $COR - MarketBeat
What You Need to Know Ahead of Cencora's Earnings Release - Barchart.com
Finanzdaten der Cencora Inc-Aktie (COR)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.76%
6.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):